Monday, 14 September 2026European Markets

GLANBIA PLC And UNIBEL Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - glanbia plc (gl9.ir) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
glanbia plc (gl9.ir) €14.65 2.31% 13.35%
unibel (unbl.pa) €980.00 1.08% 6.89%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. glanbia plc (gl9.ir)

2.31% forward dividend yield and 13.35% return on equity

glanbia plc operates as a nutrition company worldwide. the company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels. it also engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes. in addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, weight management, and bioactive solutions businesses. it operates a portfolio of brands, including optimum nutrition, bsn, isopure, nutramino, slimfast, think!, amazing grass, body & fit, and levlup brands. glanbia plc was founded in 1964 and is headquartered in kilkenny, ireland.

earnings per share

as for profitability, glanbia plc has a trailing twelve months eps of €0.93.

pe ratio

glanbia plc has a trailing twelve months price to earnings ratio of 15.75. meaning, the purchaser of the share is investing €15.75 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.35%.

more news about glanbia plc.

2. unibel (unbl.pa)

1.08% forward dividend yield and 6.89% return on equity

unibel s.a. produces and sells cheese products in france. it offers its products primarily under the la vache qui rit, kiri, mini babybel, leerdammer, boursin, pom'potes, laughs, and gogo squeez, as well as approximately thirty of local brands. the company was incorporated in 1921 and is headquartered in paris, france.

earnings per share

as for profitability, unibel has a trailing twelve months eps of €33.52.

pe ratio

unibel has a trailing twelve months price to earnings ratio of 29.24. meaning, the purchaser of the share is investing €29.24 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.89%.

volatility

unibel's last week, last month's, and last quarter's current intraday variation average was a positive 1.04%, a negative 0.34%, and a positive 1.64%.

unibel's highest amplitude of average volatility was 1.04% (last week), 2.19% (last month), and 1.64% (last quarter).

dividend yield

according to morningstar, inc., the next dividend payment is on may 22, 2023, the estimated forward annual dividend rate is 10.5 and the estimated forward annual dividend yield is 1.08%.

yearly top and bottom value

unibel's stock is valued at €980.00 at 06:30 est, under its 52-week high of €1,040.00 and higher than its 52-week low of €900.00.

more news about unibel.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,285 source documents archived
Query this data → isubstrate.com